cevimeline

Known as: Cevimelina, 2-methyspiro(1,3-oxathiolane-5,3)quinuclidine, cevimeline [Chemical/Ingredient] 
A cholinergic analogue with glandular secretion stimulatory activity. Cevimeline binds to and activates muscarinic receptors, thereby increasing the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
051019982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVE The aim of the present study was to compare the effect of low-dose pilocarpine and cevimeline as stimulants for… (More)
Is this relevant?
2008
2008
Cevimeline is an orally administered muscarinic receptor agonist that is indicated for the treatment of symptoms of dry mouth in… (More)
Is this relevant?
2007
2007
PURPOSE To study the efficacy and safety of cevimeline in two double-blind trials (Studies 003 and 004) enrolling patients with… (More)
Is this relevant?
2007
2007
PURPOSE To assess the safety of long-term cevimeline treatment of radiation-induced xerostomia in patients with head-and-neck… (More)
Is this relevant?
2007
2007
The aim of this study was to clarify the effects of the muscarinic receptor agonist, cevimeline, on saliva flow and expression of… (More)
  • figure 1
  • figure 2
  • figure 6
Is this relevant?
2006
2006
The objective of this study was to examine the clinical and immunological factors influencing the efficacy of cevimeline… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 4
Is this relevant?
2005
2005
The aim of this study is to clarify the effects of cevimeline on various components in human saliva, such as immunoglobulin A… (More)
Is this relevant?
2004
2004
PURPOSE Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by salivary and lacrimal glandular destruction… (More)
Is this relevant?
2002
2002
BACKGROUND Cevimeline hydrochloride is a cholinergic agent with muscarinic agonist activity prominently affecting the M1 and M3… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2002
2002
OBJECTIVE To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis… (More)
Is this relevant?